The role of fatty acid-binding proteins in evaluating kidney involvement in patients with ankylosing spondylitis
Kidney involvement is one of the extraarticular manifestations of ankylosing spondylitis (AS). Due to a number of disadvantages of traditional parameters for evaluating renal function, an active search is underway for new markers.Objective: to evaluate urinary excretion of liver-type and heart-type...
| Published in: | Научно-практическая ревматология |
|---|---|
| Main Authors: | L. V. Plenkina, O. V. Simonova, S. V. Popova, V. A. Rozinova |
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2020-02-01
|
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2838 |
Similar Items
Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling
by: Mariah Farrell, et al.
Published: (2023-03-01)
by: Mariah Farrell, et al.
Published: (2023-03-01)
HEART-TYPE FATTY ACID BINDING PROTEIN IN ACUTE CORONARY SYNDROME
by: E. V. Kashtanova, et al.
Published: (2012-02-01)
by: E. V. Kashtanova, et al.
Published: (2012-02-01)
The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases
by: Ben Li, et al.
Published: (2022-09-01)
by: Ben Li, et al.
Published: (2022-09-01)
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2<i>H</i>)-one as Novel Scaffold for FABP4 Inhibition
by: Letizia Crocetti, et al.
Published: (2022-10-01)
by: Letizia Crocetti, et al.
Published: (2022-10-01)
Pyridazin-3(2H)-one as New FABP4 Inhibitors Suggested by Molecular Growing Experiments
by: Giuseppe Floresta, et al.
Published: (2022-11-01)
by: Giuseppe Floresta, et al.
Published: (2022-11-01)
Fatty Acid-Binding Proteins Aggravate Cerebral Ischemia-Reperfusion Injury in Mice
by: Qingyun Guo, et al.
Published: (2021-05-01)
by: Qingyun Guo, et al.
Published: (2021-05-01)
Polymorphism in genes encoding two fatty acid binding proteins increases risk of ischemic stroke in a Chinese Han population
by: Maolin Cao, et al.
Published: (2023-04-01)
by: Maolin Cao, et al.
Published: (2023-04-01)
Tracing the evolution of fatty acid‐binding proteins (FABPs) in organisms with a heterogeneous fat distribution
by: Yuru Zhang, et al.
Published: (2020-05-01)
by: Yuru Zhang, et al.
Published: (2020-05-01)
Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients
by: Carla Harkin, et al.
Published: (2022-06-01)
by: Carla Harkin, et al.
Published: (2022-06-01)
Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-up
by: Christel Mathis, et al.
Published: (2018-12-01)
by: Christel Mathis, et al.
Published: (2018-12-01)
The role of trefoil factor-3 in assessing the influence of different types of therapy on kidney condition in patients with ankylosing spondylitis
by: L. V. Plenkina, et al.
Published: (2022-01-01)
by: L. V. Plenkina, et al.
Published: (2022-01-01)
Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01)
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01)
Coxitis in patients with ankylosing spondylitis: clinicoradio logic comparisons
by: A. G. Bochkova, et al.
Published: (2005-08-01)
by: A. G. Bochkova, et al.
Published: (2005-08-01)
OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01)
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01)
SIGNIFICANCE OF PERIPHERAL ARTHRITIS IN ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes, et al.
Published: (2014-06-01)
by: Sh. F. Erdes, et al.
Published: (2014-06-01)
Fatty-Acid-Binding Proteins: From Lipid Transporters to Disease Biomarkers
by: Shabarni Gaffar, et al.
Published: (2023-12-01)
by: Shabarni Gaffar, et al.
Published: (2023-12-01)
COURSE OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2016-09-01)
by: A. A. Godzenko, et al.
Published: (2016-09-01)
Expression, regulation and binding affinity of fatty acid-binding protein 2 in Spodoptera litura
by: Liang WEN, et al.
Published: (2020-06-01)
by: Liang WEN, et al.
Published: (2020-06-01)
EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)
Importance of evaluation of heart-type fatty acid binding protein (H-FABP) in COVID-19 Patients
by: Seyhan Ordekci, et al.
Published: (2024-02-01)
by: Seyhan Ordekci, et al.
Published: (2024-02-01)
Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01)
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01)
Fatty Acid-Binding Proteins in Psoriasis—A Review
by: Julia Nowowiejska, et al.
Published: (2022-09-01)
by: Julia Nowowiejska, et al.
Published: (2022-09-01)
Fatty Acid-Binding Proteins 4 and 5 Are Involved in the Pathogenesis of Retinal Vascular Diseases in Different Manners
by: Megumi Higashide, et al.
Published: (2022-03-01)
by: Megumi Higashide, et al.
Published: (2022-03-01)
Targeting the FABP Axis: Interplay Between Lipid Metabolism, Neuroinflammation, and Neurodegeneration
by: Chuantao Wu, et al.
Published: (2025-09-01)
by: Chuantao Wu, et al.
Published: (2025-09-01)
Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?
by: Miriam Tendler, et al.
Published: (1995-04-01)
by: Miriam Tendler, et al.
Published: (1995-04-01)
DIAGNOSIS AND TREATMENT OF COXITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: E. M. Agafonova, et al.
Published: (2018-09-01)
by: E. M. Agafonova, et al.
Published: (2018-09-01)
ANKYLOSING SPONDYLITIS IN THE VOLGA BULGARIA
by: D. I. Abdulganieva, et al.
Published: (2015-09-01)
by: D. I. Abdulganieva, et al.
Published: (2015-09-01)
Musculoskeletal losses in patients with ankylosing spondylitis
by: T. A. Raskina, et al.
Published: (2019-10-01)
by: T. A. Raskina, et al.
Published: (2019-10-01)
The distinct effects of metformin and imeglimin on high glucose-induced alterations in metabolic function and reactive oxygen species production in mouse Schwann cells are modulated by pemafibrate and/or fatty acid-binding proteins.
by: Hiroshi Ohguro, et al.
Published: (2025-08-01)
by: Hiroshi Ohguro, et al.
Published: (2025-08-01)
Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report
by: Satoshi Takashima, et al.
Published: (2022-12-01)
by: Satoshi Takashima, et al.
Published: (2022-12-01)
Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir disoproxil fumarate with low urinary β2 microglobulin levels: a retrospective observational study
by: Shinichi Hikasa, et al.
Published: (2019-06-01)
by: Shinichi Hikasa, et al.
Published: (2019-06-01)
Features of coxitis treatment in patients with ankylosing spondylitis
by: E. M. Agafonova, et al.
Published: (2018-06-01)
by: E. M. Agafonova, et al.
Published: (2018-06-01)
High expression of FABP4 and FABP6 in patients with colorectal cancer
by: Yaqin Zhang, et al.
Published: (2019-10-01)
by: Yaqin Zhang, et al.
Published: (2019-10-01)
Depression in patients with ankylosing spondylitis
by: Tianjiao Ma, et al.
Published: (2022-06-01)
by: Tianjiao Ma, et al.
Published: (2022-06-01)
A novel concept of differences in pathogenetic mechanism of diabetic retinopathy progression between type 2 diabetes mellitus patients differing in the PPARγ genotype
by: L. V. Natrus, et al.
Published: (2020-10-01)
by: L. V. Natrus, et al.
Published: (2020-10-01)
Association Between FABP3 and FABP4 Genes with Changes in Milk Composition and Fatty Acid Profiles in the Native Southern Yellow Cattle Breed
by: Mervan Bayraktar, et al.
Published: (2025-09-01)
by: Mervan Bayraktar, et al.
Published: (2025-09-01)
Kidney involvement in ankylosing spondylitis; recent findings
by: Sara Moslehi, et al.
Published: (2024-06-01)
by: Sara Moslehi, et al.
Published: (2024-06-01)
Urinary excretion of liver-type fatty acid-binding protein reflects the severity of sepsis
by: Eiichi Sato, et al.
Published: (2017-06-01)
by: Eiichi Sato, et al.
Published: (2017-06-01)
Osteopenia prevalence in ankylosing spondylitis and its correction with alphacalcidol
by: B. V. Zavodovsky, et al.
Published: (2005-02-01)
by: B. V. Zavodovsky, et al.
Published: (2005-02-01)
Instrumental diagnosis of coxitis in ankylosing spondylitis in real clinical practice
by: E. M. Agafonova, et al.
Published: (2019-01-01)
by: E. M. Agafonova, et al.
Published: (2019-01-01)
Similar Items
-
Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling
by: Mariah Farrell, et al.
Published: (2023-03-01) -
HEART-TYPE FATTY ACID BINDING PROTEIN IN ACUTE CORONARY SYNDROME
by: E. V. Kashtanova, et al.
Published: (2012-02-01) -
The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases
by: Ben Li, et al.
Published: (2022-09-01) -
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2<i>H</i>)-one as Novel Scaffold for FABP4 Inhibition
by: Letizia Crocetti, et al.
Published: (2022-10-01) -
Pyridazin-3(2H)-one as New FABP4 Inhibitors Suggested by Molecular Growing Experiments
by: Giuseppe Floresta, et al.
Published: (2022-11-01)
